CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults

Clinical trial NCT00246207 · COMPLETED

Trial details

NCT number: NCT00246207
Sponsor: Janssen-Ortho Inc., Canada
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2005-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.